Denali Therapeutics Stock (NASDAQ: DNLI) stock price, news, charts, stock research, profile.
You can purchase shares of Denali Therapeutics (NASDAQ:DNLI) through any online brokerage.
Other companies in Denali Therapeutics’s space includes: Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), Avidity Biosciences (NASDAQ:RNA), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
Denali Therapeutics has a consensus price target of $43.11.
The stock price for Denali Therapeutics (NASDAQ: DNLI) is $21.93 last updated January 17, 2025 at 4:00 PM EST.
There are no upcoming dividends for Denali Therapeutics.
Denali Therapeutics’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Denali Therapeutics.
Denali Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.